Skip to content

Clinical trials

Observational Prostatic Hyperplasia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Observational Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20181
20191
20212
20231
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed3
Recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation2
Shanghai Changzheng Hospital2
Changhai Hospital1
Chinese PLA General Hospital1
Jiangsu Taizhou People's Hospital1
Peking University Third Hospital1
Qianfoshan Hospital1
Société Internationale d'Urologie1
Xiangfu Zhou1
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia12
Prostatic Neoplasms5
Lower Urinary Tract Symptoms2
Cardiovascular Diseases1
Diabetes Mellitus1
Disease1
Metabolic Syndrome1
Neoplastic Cells, Circulating1
Renal Insufficiency, Chronic1
Urinary Bladder, Overactive1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.